SEC Form 4 · accession 0001127602-19-007177
THERMO FISHER SCIENTIFIC INC. · TMO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory J. Herrema
Officer — Senior Vice President
Period of report
Feb 19, 2019
Accepted (ET)
Feb 20, 2019 · 4:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000097745
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 19, 2019 | M | 5,400 | $73.24 | A | 31,846 | D | |
| Common StockF1 | Feb 19, 2019 | S | 5,400 | $251.51 | D | 26,446 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $73.24 | Feb 19, 2019 | M | 5,400 | D | — | Feb 26, 2020 | Common Stock | 5,400 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.50 to $251.59, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2The option vested in four equal installments on February 26, 2014, 2015, 2016, and 2017.